Analysed ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) News Sources
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
24-07-2026
yahoo.com
Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27-08-2026
yahoo.com
Ernexa Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
14-09-2026
yahoo.com
Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors
17-09-2026
yahoo.com
Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy
29-09-2026
yahoo.com
Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND
30-09-2026
yahoo.com
Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic
01-10-2026
yahoo.com
Ernexa Therapeutics’ ERNA-101 Selected for Flash Talk Presentation at Nature Conferences’ Next-Generation Cancer Therapeutics Meeting Co-Hosted by MD Anderson Cancer Center
06-10-2026
yahoo.com
What is the current price of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)?
The current price of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) is $1.98.
ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) since the previous trading day is $-0.0131.
ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) since the previous trading day is -0.6573%.
What is the most recent average sentiment score for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)?
The most recent average sentiment score for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)?
The most recent sentiment for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) is .
SEC-8K** Filing Available For ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.